We serve Chemical Name:2-hydrazinylpyridine-4-carbonitrile CAS:913839-68-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-hydrazinylpyridine-4-carbonitrile
CAS.NO:913839-68-6
Synonyms:5-cyano-2-hydrazinopyridine;2-cyano-5-hydrazinopyridine;2-hydrazinoisonicotinonitrile
Molecular Formula:C6H6N4
Molecular Weight:134.13900
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:74.73000
Exact Mass:134.05900
LogP:1.01218
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-cyano-2-hydrazinopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-hydrazinoisonicotinonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-cyano-2-hydrazinopyridine Use and application,2-hydrazinoisonicotinonitrile technical grade,usp/ep/jp grade.
Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . 2-hydrazinylpyridine-4-carbonitrile manufacturer ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 2-hydrazinylpyridine-4-carbonitrile supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 2-hydrazinylpyridine-4-carbonitrile vendor Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 2-hydrazinylpyridine-4-carbonitrile factory The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine.
